Traws Pharma Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 730.00 K | $1.34 M | 0.00% | 8.87% |
| IKARIAN CAPITAL, LLC | 05/15/2026 | 678.14 K | $1.24 M | 0.00% | 8.24% |
| ORBIMED ADVISORS LLC | 05/15/2026 | 605.53 K | $1.11 M | 0.00% | 7.36% |
| 05/15/2026 | 511.71 K | $936.44 K | -28.29% | 6.22% | |
| DAUNTLESS INVESTMENT GROUP, LLC | 05/14/2026 | 417.00 K | $763.11 K | 100.00% | 5.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2026 | 194.54 K | $356.00 K | 0.00% | 2.36% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 154.10 K | $282.00 K | -0.22% | 1.87% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 77.10 K | $141.10 K | 25.06% | 0.94% |
| PALUMBO WEALTH MANAGEMENT LLC | 05/12/2026 | 61.18 K | $111.95 K | 100.00% | 0.74% |
| 05/15/2026 | 55.19 K | $101.00 K | 100.00% | 0.67% | |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 31.80 K | $58.20 K | 100.00% | 0.39% |
| STATE STREET CORP | 05/15/2026 | 25.80 K | $47.22 K | 0.00% | 0.31% |
| JANE STREET GROUP, LLC | 05/12/2026 | 21.24 K | $38.87 K | 100.00% | 0.26% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 19.24 K | $35.22 K | 0.00% | 0.23% |
| LYNX1 CAPITAL MANAGEMENT LP | 05/04/2026 | 15.08 K | $27.59 K | 100.00% | 0.18% |
| BLACKROCK, INC. | 05/13/2026 | 9.96 K | $18.22 K | 0.00% | 0.12% |
| UBS GROUP AG | 05/05/2026 | 4.05 K | $7.42 K | -47.51% | 0.05% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 3.96 K | $7.25 K | 100.00% | 0.05% |
| MORGAN STANLEY | 05/15/2026 | 3.73 K | $6.82 K | 100.00% | 0.05% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 262 | $479 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 128 | $234 | -20.99% | 0.00% |
| FMR LLC | 05/15/2026 | 23 | $42 | 1,050.00% | 0.00% |
| CASSADAY & CO WEALTH MANAGEMENT LLC | 05/07/2026 | 11 | $21 | 100.00% | 0.00% |
| 06/09/2026 | 5 | $9 | 100.00% | 0.00% | |
| JONES FINANCIAL COMPANIES LLLP | 05/15/2026 | 2 | $4 | 100.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 05/07/2026 | 2 | $4 | 100.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 05/11/2026 | 2 | $4 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 05/11/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| 06/04/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Traws Pharma Inc. institutional Ownership - FAQ's
During the previous two years, 31 institutional investors and hedge funds held shares of Traws Pharma Inc.. The most heavily invested institutionals were:
ADAGE CAPITAL PARTNERS GP, L.L.C.: 730,000
Ikarian Capital, LLC: 678,142
ORBIMED ADVISORS LLC: 605,531
Dauntless Investment Group, LLC: 416,998
BOOTHBAY FUND MANAGEMENT, LLC: 194,536
ADAR1 Capital Management, LLC: 154,098
43.99% of Traws Pharma Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.14 M shares in the last 24 months. This purchase volume represents approximately $5.24 M in transactions.